Los Angeles Times

POTS, Cholesterol, and the Balancing Act of Heart Health

Cholesterol management is a long game involving LDL/HDL balance, not a quick detox. POTS (Postural Orthostatic Tachycardia Syndrome) represents a mechanical failure of blood flow, distinct from ...
BioSpace

Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy

DUBLIN--(BUSINESS WIRE)--Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise ...
BioTechniques

Who won the 2025 Nobel Prize for Physiology or Medicine?

The discovery and characterization of regulatory T cells has been selected as Nobel Prize winning research, with three researchers selected to share the prize. Mary Brunkow (Institute for Systems ...
The New York Times

Nobel Prize in Physiology or Medicine Is Awarded for Work on Immune Systems

Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi were awarded the prize for research showing how the body regulates its immune responses. By Gina Kolata and Ali Watkins Mary E. Brunkow, Fred ...
Scientific Research Publishing

Raj, S.R. (2020) The Postural Tachycardia Syndrome: Pathophysiology, Diagnosis, and Management. Heart Rhythm, 17, 1-7.

ABSTRACT: Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogeneous disorder characterized by an excessive increase in heart rate upon standing without significant orthostatic hypotension.
Seeking Alpha

Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple ...

DUBLIN, Aug. 25, 2025 /PRNewswire/ -- Theravance Biopharma (TBPH), Inc. ("Theravance Biopharma" or the "Company"), today announced completion of enrollment in the open-label portion of its pivotal ...